Phase III Beckons For A Short-Course Seasonal Allergic Rhinitis Jab

 
• By John Davis

A marketing approval for a seasonal allergic rhinitis vaccine from Allergy Therapeutics has moved nearer with positive top-line Phase II results that define the dose to be used in a Phase III study.

Grass
Various grasses produce large quantities of allergenic material • Source: Shutterstock

More from Clinical Trials

More from R&D